Tesamorelin Side Effects: HIV Trial Data Breakdown (2026)
IGF-1 Elevation as a Pharmacologic Signal Tesamorelin raises IGF-1 by stimulating endogenous GH release. The Phase 3 trial reported mean IGF-1 elevation of approximately 80% from baseline at 26 weeks (PMID 18057338). FD…
Read article